More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

Appendix 4C & Q2 FY23 Activities Report

Jan 11, 2023 at 9:42 PM EST · Issued by Anatara Lifesciences Ltd

Filed with ASX · Jan 11, 2023 at 9:42 PM EST

On 6ix: 6ix.com/news/appendix-4c-and-q2-fy23-activities-report

Anatara Lifesciences Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anatara Lifesciences Ltd on 6ix

Story so far

  • Appendix 4C & Q1 FY23 Activities ReportOct 28, 2022
  • Q4 FY22 Activities ReportAug 1, 2022
  • Appendix 4C and Q3 FY22 Activities ReportApr 29, 2022

Earlier from Anatara Lifesciences

  • Completion of Non-renounceable Entitlement Offer and ShortfaNov 24, 2022
  • Appendix 4C & Q1 FY23 Activities ReportOct 27, 2022
  • Placement and Entitlement OfferOct 20, 2022
  • Entitlement Offer ProspectusOct 20, 2022
  • Anatara Investor PresentationOct 13, 2022

Later from Anatara Lifesciences

  • Revised Appendix 4CJan 13, 2023
  • Placement of Shortfall from Entitlement OfferFeb 21, 2023
  • Half Yearly Report and AccountsFeb 23, 2023
  • Anatara Company UpdateMar 9, 2023
  • Appendix 4C & Q3 FY23 Activities ReportApr 19, 2023
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer